
ENVB
Healthcare · Biotechnology · $6.8M market cap
$1.51-0.01 (-0.3%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | — | — | — |
| Aug 14, 2026 | Time not confirmed | — | -0.76 | — |
| May 19, 2026 | Time not confirmed | — | -1.08 | — |
| Mar 27, 2026 | Time not confirmed | — | -3.81 | — |
| Nov 14, 2025 | Time not confirmed | -0.35 | -10.81 | -2988.6% |
| Aug 14, 2025 | Time not confirmed | -0.35 | -11.65 | -3228.6% |
| May 13, 2025 | Before the open | -0.40 | -4.82 | -1104.2% |
| Mar 28, 2025 | After the close | -2.76 | -2.03 | +26.4% |
| Nov 14, 2024 | After the close | -93.60 | -43.20 | +53.8% |
| Aug 12, 2024 | After the close | -99.00 | -45.00 | +54.5% |
| May 15, 2024 | After the close | -139.50 | -109.80 | +21.3% |
| Mar 26, 2024 | Before the open | -1.54 | -1.47 | +4.5% |
| Nov 13, 2023 | After the close | -376.20 | -287.12 |
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and…
| +23.7% |
| Aug 11, 2023 | After the close | -117.00 | -450.42 | -285.0% |
| May 15, 2023 | Before the open | -2.23 | -4.24 | -89.9% |
| Mar 31, 2023 | After the close | -525.60 | -344.11 | +34.5% |
| Nov 14, 2022 | After the close | -720.00 | -582.21 | +19.1% |
| Aug 12, 2022 | After the close | -675.00 | -818.08 | -21.2% |
| May 13, 2022 | After the close | -1080.00 | -990.00 | +8.3% |
| Mar 31, 2022 | After the close | -8.00 | -89.00 | -1012.5% |
| Nov 15, 2021 | Before the open | -1260.00 | -1080.00 | +14.3% |
| Aug 6, 2021 | After the close | -1575.00 | -1800.00 | -14.3% |
| May 17, 2021 | After the close | -9.50 | -0.04 | +99.6% |
| Nov 16, 2020 | After the close | — | -0.04 | — |
| Aug 14, 2020 | After the close | — | -0.48 | — |
| May 15, 2020 | After the close | — | -0.04 | — |
| Nov 8, 2019 | After the close | -5.00 | -0.03 | +99.5% |
| Aug 14, 2019 | Before the open | -150.00 | -0.75 | +99.5% |
| May 14, 2019 | Before the open | — | -1.00 | — |
| Mar 26, 2019 | Before the open | -200.00 | -1600.00 | -700.0% |
| Nov 14, 2018 | After the close | -250.00 | -300.00 | -20.0% |
| Aug 14, 2018 | Before the open | -400.00 | -300.00 | +25.0% |
| May 15, 2018 | After the close | -0.08 | -2.25 | -2712.5% |